Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teprenone ± probiotics for NSAID-associated small intestinal mucosal injury
ChiCTR2500114148Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of teprenone and lactobacillus acidophilus in enteropathy (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Number of small intestinal mucosal injuries at week 8. Started Dec 2025; status: recruiting.
02
Drugs
teprenonelactobacillus acidophilus
03
Conditions
enteropathy
Beyond the preview
Go deeper on ChiCTR2500114148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114148.